GlaxoSmithKline Pakistan

Pharmaceutical company

  • Erum Shakir Rahim (CEO)
  • Hasham Ali Baber (CFO)
RevenueIncrease Rs. 41.84 billion (US$140 million)[1] (2022)Decrease Rs. 5.10 billion (US$18 million)[1] (2022)
Net income
Decrease Rs. 2.46 billion (US$8.5 million)[1] (2022)Total assetsIncrease Rs. 22.63 billion (US$78 million)[1] (2022)Total equityIncrease Rs. 21.05 billion (US$73 million)[1] (2022)
Number of employees
1,768[1] (2022)ParentGSKWebsitewww.pk.gsk.com

GlaxoSmithKline Pakistan is a Pakistani pharmaceutical company which is a subsidiary of British company GSK.[2] It is the largest pharmaceutical company in Pakistan.

History

The company started its operations in Pakistan as Glaxo Laboratories Pakistan Ltd and was listed on the Karachi Stock Exchange in 1951.[3]

GSK Pakistan equation was formed when Beecham, Glaxo Welcome and Smith Kline, all having a big name in the pharmaceutical market and that were separate entities before, merged in 2002.[4]

In December 2008, GSK Pakistan acquired operations of Bristol Myers Squibb in Pakistan for approximately US$36.5 million.[5]

In December 2010, the company acquired Stiefel Laboratories operations in Pakistan.[6]

GlaxoSmithKline's former logo, 2001-9 June 2022

GlaxoSmithKline Consumer Healthcare Pakistan Limited (GSKCH)

In 2015, GlaxoSmithKline Consumer Healthcare Pakistan Limited (GSKCH) was demerged from GlaxoSmithKline Pakistan Limited (GLAXO).[7]

In 2016, GSKCH started operations as an independent company.[7]

In 2017, GSKCH got listed on PSX.[7]

GLAXO vs GSKCH

GLAXO (GlaxoSmithKline Pakistan Limited) manufactures and markets a wide variety of prescription medicines and vaccines.[7]

GSKCH (GlaxoSmithKline Consumer Healthcare Pakistan Limited) sells over-the-counter medicines and consumer products.[7]

References

  1. ^ a b c d e f "GSK PK Annual Report 2022" (PDF). pk.gsk.com. Retrieved 30 November 2023.
  2. ^ "GlaxoSmithKline Pakistan Limited – a company overview (2014 version)". Business Recorder (newspaper). 2 December 2014. Retrieved 3 November 2022.
  3. ^ "GlaxoSmithKline Pakistan Limited – a company overview (2016 version)". Business Recorder (newspaper). 1 September 2016. Retrieved 3 November 2022.
  4. ^ Hussain, Dilawar (27 August 2003). "GlaxoSmithKline Pakistan - a company profile". Dawn (newspaper). Retrieved 3 November 2022.
  5. ^ Khan, Aamir Shafaat (23 December 2008). "Glaxo acquires Bristol Myers". Dawn (newspaper). Retrieved 3 November 2022.
  6. ^ "GSK Pakistan takes over Stiefel's local operations". The Express Tribune (newspaper). 3 December 2010. Retrieved 3 November 2022.
  7. ^ a b c d e "GLAXO: earnings in red". Business Recorder (newspaper). 1 September 2022. Retrieved 3 November 2022.
  • v
  • t
  • e
GSK
Subsidiaries
Current
  • GlaxoSmithKline Pakistan
  • GlaxoSmithKline Pharmaceuticals Ltd
  • Stiefel Laboratories
  • Tesaro
  • ViiV Healthcare (85%)
Former
Predecessors,
acquisitionsProducts
Current
Pharma
Vaccines
Former
People
Board of
Directors
Other
LitigationOther
  • Category
  • v
  • t
  • e
Pakistan Companies of the KSE 100 Index
As of July 2022